Issue 6/2023
Content (20 Articles)
Up Front
Evidence-based European recommendations for the dietary management of diabetes
Anne-Marie Aas, Mette Axelsen, Chaitong Churuangsuk, Kjeld Hermansen, Cyril W. C. Kendall, Hana Kahleova, Tauseef Khan, Michael E. J. Lean, Jim I. Mann, Eva Pedersen, Andreas Pfeiffer, Dario Rahelić, Andrew N. Reynolds, Ulf Risérus, Angela Albarosa Rivellese, Jordi Salas-Salvadó, Ursula Schwab, John L. Sievenpiper, Anastasia Thanopoulou, Emeritus Matti Uusitupa
Sex differences in type 2 diabetes
Alexandra Kautzky-Willer, Michael Leutner, Jürgen Harreiter
Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders
Jacqueline M. Ratter-Rieck, Michael Roden, Christian Herder
The prediabetes conundrum: striking the balance between risk and resources
Martin B. Blond, Kristine Færch, Christian Herder, Dan Ziegler, Coen D. A. Stehouwer
Significant impact of time-of-day variation on metformin pharmacokinetics
Denise Türk, Nina Scherer, Dominik Selzer, Christiane Dings, Nina Hanke, Robert Dallmann, Matthias Schwab, Peter Timmins, Valerie Nock, Thorsten Lehr
No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study
Linda C. A. Drenthen, Mandala Ajie, Evertine J. Abbink, Laura Rodwell, Dick H. J. Thijssen, Cees J. Tack, Bastiaan E. de Galan
Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial
Marie Pigeyre, Hertzel Gerstein, Emma Ahlqvist, Sibylle Hess, Guillaume Paré
Childhood adiposity and novel subtypes of adult-onset diabetes: a Mendelian randomisation and genome-wide genetic correlation study
Yuxia Wei, Tom G. Richardson, Yiqiang Zhan, Sofia Carlsson
Altered blood gene expression in the obesity-related type 2 diabetes cluster may be causally involved in lipid metabolism: a Mendelian randomisation study
Juliette A. de Klerk, Joline W. J. Beulens, Hailiang Mei, Roel Bijkerk, Anton Jan van Zonneveld, Robert W. Koivula, Petra J. M. Elders, Leen M. ’t Hart, Roderick C. Slieker
Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes
Najda Rudman, Simranjeet Kaur, Vesna Simunović, Domagoj Kifer, Dinko Šoić, Toma Keser, Tamara Štambuk, Lucija Klarić, Flemming Pociot, Grant Morahan, Olga Gornik
Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice
Xinzhi Li, Ying Yang, Zhenzhi Li, Yuqin Wang, Jingting Qiao, Zheng Chen
Methylation of histone H3 lysine 4 is required for maintenance of beta cell function in adult mice
Ben Vanderkruk, Nina Maeshima, Daniel J. Pasula, Meilin An, Cassandra L. McDonald, Priya Suresh, Dan S. Luciani, Francis C. Lynn, Brad G. Hoffman
Infant gut microbiome composition correlated with type 1 diabetes acquisition in the general population: the ABIS study
Malin Bélteky, Patricia L. Milletich, Angelica P. Ahrens, Eric W. Triplett, Johnny Ludvigsson
The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes
Paola S. Apaolaza, Diana Balcacean, Jose Zapardiel-Gonzalo, Teresa Rodriguez-Calvo
Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling
Yang Xiao, Yanfei Wang, Jiyoon Ryu, Wei Liu, Hailan Zou, Rong Zhang, Yin Yan, Zhe Dai, Deling Zhang, Lu-Zhe Sun, Feng Liu, Zhiguang Zhou, Lily Q. Dong
Drug target Mendelian randomisation: are we really instrumenting drug use?
Emma L. Anderson, Dylan M. Williams
Drug target Mendelian randomisation: are we really instrumenting drug use? Reply to Anderson EL, Williams DM [letter]
Jie Zheng, Tom R. Gaunt, Min Xu, George Davey Smith, Yufang Bi
Correction to: Sex differences in type 2 diabetes
Alexandra Kautzky-Willer, Michael Leutner, Jürgen Harreiter